A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients

Canadian Respiratory Journal

Volumn 15, Issue 5, 2008, Pages 259-262

  Nikolaizik, Wilfried H ^a   Vietzke, Delia ^a   Ratjen, Felix ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Antibiotics; Cystic fibrosis; Infection; Inhalation; Lung function; Tobramycin

Indexed keywords

COLISTIN; TOBRAMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; LUNG FUNCTION TEST; MALE; MULTIPLE CYCLE TREATMENT; OXYGEN SATURATION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAL CAPACITY;

EID: 57349142362     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/202464     Document Type: Article

References (10)

1. Gappa M, Steinkamp G, Tümmler B, von der Hardt H. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Scand J Gastroenterol Suppl. 1988;143:74-6.
2. MacLusky IB, Gold R, Corey M, Levison H. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989;7:42-8.
3. Ryan G, Mukhopadhyay S, Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2000:CD001021.
4. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340:23-30.
5. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia: WB Saunders, 1971.
6. Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 1976;125:110-8.
7. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
8. American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
9. Hodson ME, Gallagher CG, Govan JR. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 2002;20:658-64.
10. Nikolaizik WH, Trociewicz K, Ratien F. Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis. Eur Respir J 2002;20:122-126.